质子治疗用于头颈癌:拓展治疗窗口
质子束治疗中心在全球迅速增加,其物理特性在头颈癌复杂解剖和敏感器官周围具有剂量学优势。光子与质子技术剂量分布比较提示毒性 sparing 获益,近期已被大量临床数据证实。本综述旨在界定该方法在当代多学科头颈癌管理中的作用。
要点
- 质子束物理特性较光子技术提高放射精度,尤其适合头颈癌复杂解剖和敏感器官。
- HPV相关疾病中年轻患者治愈后需长期承受不良反应,减毒和个体化治疗重要性再获关注。
- 光子与质子剂量分布比较提示毒性 sparing 获益,近期已被大量临床数据证实。
核心结论
- 本综述尝试界定质子治疗在当代多学科管理各类头颈癌中的作用。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 质子束治疗中心数量在美国及全球迅速增加。
- 质子束物理特性在放射精度方面较广泛使用的光子技术具有重要优势。
- 头颈癌中质子束治疗尤其适合肿瘤复杂解剖和周围敏感器官。
- 光子与质子技术放射剂量分布比较提示毒性 sparing 方面有相当获益,但近期才被大量临床数据证实。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Use of proton beam therapy has expanded, with the number of proton centres rapidly increasing not only in the USA but also worldwide. The physical characteristics of the proton beam offer important advantages versus widely used photon techniques in terms of radiation precision. In head and neck cancer in particular, proton beam therapy is uniquely suited for the complex anatomy of tumours and sensitive surrounding organs. De-intensification and personalisation of treatment to limit toxicity are of renewed importance in the context of human papilloma virus-associated disease, in which young patients will be cured but bear the consequences of adverse effects for decades. Comparisons of radiation dose distributions between photon and proton techniques suggest considerable benefit in terms of toxicity sparing, but this has only recently been confirmed by substantial clinical data. In this Review, we attempt to define the role of this method in the contemporary multidisciplinary management of various types of head and neck cancer.
引用
- Leeman JE, Romesser PB, Zhou Y, et al. Proton therapy for head and neck cancer: expanding the therapeutic window. Lancet Oncol. 2017. PMID: 28456587. doi:10.1016/S1470-2045(17)30179-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。